Literature DB >> 22226265

Basic performance of an enzymatic method for glycated albumin and reference range determination.

Takuji Kohzuma1, Tamotsu Yamamoto, Yumiko Uematsu, Zak K Shihabi, Barry I Freedman.   

Abstract

BACKGROUND: Glycated albumin (GA) is a medium-term glycemic control marker of diabetes and may be more sensitive to changes in plasma glucose than hemoglobin A1c. We studied where and how many fructosyl groups bind to albumin, and which glycation sites are measured by the enzymatic method for GA. We also studied the basic performance of the enzymatic method for GA.
METHODS: Glycated albumin was measured using an enzymatic method (Lucica®GA-L, Asahi Kasei Pharma) on a biochemical autoanalyzer. Molecular weights of purified GA and nonglycated albumin were measured by a mass spectrometry system. Two hundred one healthy volunteers with normal results of oral glucose tolerance testing were recruited to determine the reference range in Americans.
RESULTS: The present method measured only glycated amino acids from albumin in serum protein. We estimate that the number of glycated amino acids measured by this method was approximately two per molecule of albumin. The general performance (sensitivity, specificity, reproducibility, linearity, interference) of the method was good. The reference range of GA% in Americans with normal glucose tolerance was determined to be 11.9-15.8% (mean ± 2 standard deviations). Significant differences were not observed between the sexes; however, race differences were observed (higher levels in blacks relative to whites).
CONCLUSIONS: The method was specific for measuring glycated amino acids in albumin and had good basic performance characteristics. The reference range in Americans was 11.9-15.8%. This method may be a useful indicator for diabetes control.
© 2011 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226265      PMCID: PMC3262714          DOI: 10.1177/193229681100500619

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  28 in total

Review 1.  Clinical impact of glycated albumin as another glycemic control marker.

Authors:  Masafumi Koga; Soji Kasayama
Journal:  Endocr J       Date:  2010-08-17       Impact factor: 2.349

2.  Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control.

Authors:  Satomi Takahashi; Hiroshi Uchino; Tomoaki Shimizu; Akio Kanazawa; Yoshifumi Tamura; Ken Sakai; Hirotaka Watada; Takahisa Hirose; Ryuzo Kawamori; Yasushi Tanaka
Journal:  Endocr J       Date:  2006-12-11       Impact factor: 2.349

3.  Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA.

Authors:  M P Cohen; E Hud
Journal:  J Immunol Methods       Date:  1989-09-01       Impact factor: 2.303

4.  Racial differences in glycemic markers: a cross-sectional analysis of community-based data.

Authors:  Elizabeth Selvin; Michael W Steffes; Christie M Ballantyne; Ron C Hoogeveen; Josef Coresh; Frederick L Brancati
Journal:  Ann Intern Med       Date:  2011-03-01       Impact factor: 25.391

5.  Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus.

Authors:  C E Guthrow; M A Morris; J F Day; S R Thorpe; J W Baynes
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin.

Authors:  Reiko Kisugi; Takuji Kouzuma; Tamotsu Yamamoto; Setsuko Akizuki; Hiroyasu Miyamoto; Yasutoshi Someya; Junichi Yokoyama; Ikurho Abe; Noriyuki Hirai; Akihiro Ohnishi
Journal:  Clin Chim Acta       Date:  2007-04-12       Impact factor: 3.786

7.  Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography.

Authors:  R W Yatscoff; G J Tevaarwerk; J C MacDonald
Journal:  Clin Chem       Date:  1984-03       Impact factor: 8.327

8.  Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

Authors:  Rita Paroni; Ferruccio Ceriotti; Renzo Galanello; Giovan Battista Leoni; Alessandra Panico; Emanuele Scurati; Renata Paleari; Liliana Chemello; Vania Quaino; Luca Scaldaferri; Annunziata Lapolla; Andrea Mosca
Journal:  Clin Biochem       Date:  2007-08-10       Impact factor: 3.281

9.  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites.

Authors:  N Iberg; R Flückiger
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

Review 10.  Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?

Authors:  M P Cohen
Journal:  J Diabet Complications       Date:  1988 Oct-Dec
View more
  32 in total

Review 1.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

2.  Monitoring Glycemic Control in End-Stage Renal Disease: What Should Be Measured?

Authors:  Elizabeth Selvin; David B Sacks
Journal:  Clin Chem       Date:  2016-12-14       Impact factor: 8.327

3.  Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.

Authors:  Kerry J Welsh; M Sue Kirkman; David B Sacks
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

Review 4.  Glycated albumin: from biochemistry and laboratory medicine to clinical practice.

Authors:  Elena Dozio; Nicola Di Gaetano; Peter Findeisen; Massimiliano Marco Corsi Romanelli
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

5.  Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.

Authors:  Elizabeth Selvin; Bethany Warren; Xintong He; David B Sacks; Amy K Saenger
Journal:  Clin Chem       Date:  2018-02-07       Impact factor: 8.327

6.  Emerging trends in optical sensing of glycemic markers for diabetes monitoring.

Authors:  Rishikesh Pandey; Narahara Chari Dingari; Nicolas Spegazzini; Ramachandra R Dasari; Gary L Horowitz; Ishan Barman
Journal:  Trends Analyt Chem       Date:  2015-01-01       Impact factor: 12.296

7.  Usefulness of glycated albumin assay for diabetes monitoring.

Authors:  Randie R Little
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

8.  Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference.

Authors:  Elizabeth Selvin
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

9.  GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.

Authors:  Cyrus V Desouza; Julio Rosenstock; Rong Zhou; Richard G Holcomb; Vivian A Fonseca
Journal:  Endocr Pract       Date:  2015-07-27       Impact factor: 3.443

10.  Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Elizabeth Selvin; Andreea M Rawlings; Morgan Grams; Ronald Klein; A Richey Sharrett; Michael Steffes; Josef Coresh
Journal:  Lancet Diabetes Endocrinol       Date:  2014-01-15       Impact factor: 32.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.